Intellia Therapeutics Head office building

Investors
& Media

Banner Menu

Press Releases

Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026

Read More

Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London

Read More

Upcoming
Events

Stock Information

Minimum 15 minutes delayed. Source: LSEG